Published Online: Wednesday, September 26, 2012

In this video from Memorial Sloan-Kettering Cancer Center, several experts discuss new treatments for melanoma, including vemurafenib (Zelboraf), which targets the activity of mutated BRAF genes found in approximately half of melanoma tumors, and ipilimumab (Yervoy), which uses the immune system to fight melanoma. The participants in the discussion include Paul Chapman, MD, an oncologist and melanoma expert, and Charlotte Ariyan, MD, PhD, a surgeon specializing in surgical oncology who conducts research into immunotherapy for cancer.